arrow
B

Brandon W. Higgs

genmab us, inc.
H指数:47
被引数:8,923

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Phase I/II Study of AXL-Specific Antibody-Drug Conjugate Enapotamab Vedotin in Patients with Advanced Solid Tumors

晚期实体瘤患者AXL特异性抗体药物偶联物Enapotamab Vedotin的I/II期研究

2025-11-010
OA
Acasunlimab, an Fc-inert PD-L1x4-1BB bispecific antibody, combined with PD-1 blockade potentiates antitumor immunity via complementary immune modulatory effects

Acasunlimab,一种Fc无活性PD-L1x4-1BB双特异性抗体,与PD-1阻断联合应用可通过互补的免疫调节效应增强抗肿瘤免疫。

2025-04-100
PRE
Biliary atresia is associated with polygenic susceptibility in ciliogenesis and planar polarity effector genes
2023-12-0110
OAAI
High-throughput mediation analysis of human proteome and metabolome identifies mediators of post-bariatric surgical diabetes control
2021-11-2922
OAAI
Biliary-Atresia-Associated Mannosidase-1-Alpha-2 Gene Regulates Biliary and Ciliary Morphogenesis and Laterality
2020-10-3015
OAAI
Tumor mutational burden and immune infiltration as independent predictors of response to neoadjuvant immune checkpoint inhibition in early TNBC in GeparNuevo

肿瘤突变负荷和免疫浸润是GeparNuevo早期TNBC对新辅助免疫检查点抑制反应的独立预测因子

2020-09-01142
OAAI